Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study
Alette H. Ruarus(Amsterdam University Medical Centers), Martijn R. Meijerink(Amsterdam University Medical Centers), Hester J. Scheffer(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tanja D. de Gruijl(Dutch Cancer Society), Sanne Nieuwenhuizen(Amsterdam University Medical Centers), Eran van Veldhuisen(Amsterdam Neuroscience), Krijn P. van Lienden(University of Amsterdam), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Robbert S. Puijk(Amsterdam University Medical Centers), Barbara M. Zonderhuis(Amsterdam Neuroscience), Laurien G. P. H. Vroomen(Amsterdam University Medical Centers), Bart Geboers(Amsterdam University Medical Centers), Jan J.J. de Vries(Amsterdam University Medical Centers), Marc G. Besselink(Amsterdam Neuroscience)
Cited by 151
Related Papers
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Endoscopic Transgastric vs Surgical Necrosectomy for Infected Necrotizing Pancreatitis
|JAMA|2012|735
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|715
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597